PHARPharming Group N.V.
$9.70-34% 1Y
$9.70
$9.7052 weeks$21.18
Price
-34%1YEnd-of-day closes, not the intraday tick.
A mixed picture: the questions disagree
Quality mixed, a flag to check, undemanding price, growth steady, the market against it.
P/En/a
Market value$685.0M
1 year-34%
5 years-12%
Charts
As reported to the SEC, without any scoring.
For the full year FY2025, revenue was $376M (+27% year on year) and net income $2.5M.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.